Kewaunee Scientific Corporation (KEQU) Financial Statements (2026 and earlier)

Company Profile

Business Address 2700 W FRONT ST
STATESVILLE, NC 28677
State of Incorp. DE
Fiscal Year End April 30
Industry (SIC) 3821 - Laboratory Apparatus and Furniture (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

1/31/2026
Q3
10/31/2025
Q2
7/31/2025
Q1
4/30/2025
Q4
1/31/2025
Q3
10/31/2024
Q2
7/31/2024
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,59419,48914,9429,45425,96324,211
Cash and cash equivalent12,59419,48914,9429,45425,96324,211
Restricted cash and investments1,0859522,2222,8813,701975
Receivables59,01756,89762,38457,41941,88543,545
Inventory, net of allowances, customer advances and progress billings35,49934,92332,84931,56018,65919,285
Inventory35,49934,92332,84931,56018,65919,285
Other undisclosed current assets5,4454,8875,9667,2986,2284,683
Total current assets:113,640117,148118,363108,61296,43692,699
Noncurrent Assets
Operating lease, right-of-use asset11,45912,02212,96513,9746,9416,944
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization23,15522,78123,17423,84916,99017,112
Intangible asset, including goodwill, after accumulated amortization29,55029,93430,31832,366  
Goodwill12,48712,48712,48714,150  
Intangible asset, excluding goodwill, after accumulated amortization17,06317,44717,83118,216  
Deferred income tax assets3,8314,2113,9943,8838,3058,091
Other noncurrent assets7,4407,3905,8406,4645,8067,172
Total noncurrent assets:75,43576,33876,29180,53638,04239,319
TOTAL ASSETS:189,075193,486194,654189,148134,478132,018
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33,17338,07839,59134,00126,45625,248
Accounts payable22,66026,32727,03324,53021,45820,619
Accrued liabilities10,51311,75112,5589,4714,9984,629
Deferred revenue4,3424,9836,0737,7736,2394,937
Debt3,0673,0894,0823,102109113
Other undisclosed current liabilities5,2284,3363,9665,2953,6676,389
Total current liabilities:45,81050,48653,71250,17136,47136,687
Noncurrent Liabilities
Long-term debt and lease obligation32,56834,52234,83435,113156222
Long-term debt, excluding current maturities32,25034,38034,68534,963  
Finance lease, liability318142149150156222
Liabilities, other than long-term debt8,8409,52810,25911,0906,5376,846
Deferred income tax liabilities1,2171,1611,0981,0931,0421,273
Other liabilities349353364447460462
Operating lease, liability7,2748,0148,7979,5505,0355,111
Other undisclosed noncurrent liabilities30,14030,08129,60430,65330,65730,750
Total noncurrent liabilities:71,54874,13174,69776,85637,35037,818
Total liabilities:117,358124,617128,409127,02773,82174,505
Equity
Equity, attributable to parent69,85267,07864,45760,80159,32856,023
Common stock7,4237,4217,3537,3537,3537,353
Treasury stock, value(3,647)(3,647)(3,647)(2,051)(2,051)(2,051)
Additional paid in capital5,9965,5055,6355,2664,8854,512
Accumulated other comprehensive loss(4,377)(4,213)(3,803)(3,836)(3,574)(3,498)
Retained earnings64,45762,01258,91954,06952,71549,707
Equity, attributable to noncontrolling interest1,8651,7911,7881,3201,3291,490
Total equity:71,71768,86966,24562,12160,65757,513
TOTAL LIABILITIES AND EQUITY:189,075193,486194,654189,148134,478132,018

Income Statement (P&L) ($ in thousands)

1/31/2026
Q3
10/31/2025
Q2
7/31/2025
Q1
4/30/2025
Q4
1/31/2025
Q3
10/31/2024
Q2
7/31/2024
Q1
Revenues70,09671,10477,14867,16747,76448,393
Cost of revenue
(Cost of Product and Service Sold)
(50,376)(50,174)(53,110)(48,788)(33,812)(35,905)
Gross profit:19,72020,93024,03818,37913,95212,488
Operating expenses(15,613)(16,120)(15,538)(16,129)(9,518)(9,913)
Operating income:4,1074,8108,5002,2504,4342,575
Interest and debt expense(1,061)(1,058)(1,163)(1,137)(442)(472)
Income from continuing operations before equity method investments, income taxes:3,0463,7527,3371,1133,9922,103
Other undisclosed income (loss) from continuing operations before income taxes407168(188)162(61)327
Income from continuing operations before income taxes:3,4533,9207,1491,2753,9312,430
Income tax expense (benefit)(915)(761)(2,202)108(916)(192)
Net income:2,5383,1594,9471,3833,0152,238
Net loss attributable to noncontrolling interest(93)(66)(97)(29)(7)(45)
Net income available to common stockholders, diluted:2,4453,0934,8501,3543,0082,193

Comprehensive Income ($ in thousands)

1/31/2026
Q3
10/31/2025
Q2
7/31/2025
Q1
4/30/2025
Q4
1/31/2025
Q3
10/31/2024
Q2
7/31/2024
Q1
Net income:2,5383,1594,9471,3833,0152,238
Other comprehensive income (loss)(164)(410)33(262)(76)(116)
Comprehensive income:2,3742,7494,9801,1212,9392,122
Comprehensive loss, net of tax, attributable to noncontrolling interest(93)(66)(97)(29)(7)(45)
Comprehensive income, net of tax, attributable to parent:2,2812,6834,8831,0922,9322,077

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: